FDA approves new drug for high blood pressure

the U.SFood and Drug Administration approved theof Novartis
, Switzerland,to develop a new drug for the treatment ofhypertensionTekturna,this is the first renin inhibitorhypertensiontreatment drug approved by the Drug Enforcement AdministrationAccording to the,Tekturna is a new molecular entity,works by inhibiting renin associated with blood pressure regulationIt can function at the beginning of the blood pressure regulation process, and other hypertension treatmentdrugs are only at the end of the blood pressure regulation process Tekturna's safety and efficacy in lowering blood pressure have been proven in six clinical trials, and its blood pressure-lowering effects can last up to a year, the FDA said If used in combination with diuretic antihypertensive drug hydrochloroquine, the effect of bucking is more obvious The most common side effect of taking Tekturna is diarrhea The FDA warns that pregnant women ban the drug because it can harm the fetus or even cause stillbirths Hypertension is known as the "silent killer" because it usually shows no obvious symptoms at the beginning of the disease and develops extremely hiddenly The FDA said in a statement that an estimated one-quarter of Americans are affected by varying degrees of high blood pressure, which also increases the risk of from diseases such as stroke , heart disease
, kidney failure, and heart failure (
Xinhua Provides without permission, is strictly prohibited from reprinting)